Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Key results: 12 mg dose: Average weight loss of 24.2 percent of body weight 8 mg dose: Average weight loss of 22.8 percent 4 mg dose: Average weight loss of 17.0 percent Over 90 percent of participants at 8 or 12 mg lost at least 10 percent of body weight Over 75 percent at 12 mg lost at least 20 percent Crucially, the weight loss curve had not yet plateaued at 48 weeks, suggesting longer treatment may produce even greater results
This is the fastest weight loss period (weeks 12 to 24 in trials), and the experience becomes straightforward: reduced appetite, steady weight loss, and improving health markers
A higher initial payment may be required for some consumers
Retatrutide has not yet initiated a dedicated cardiovascular outcome trial, though Phase 3 trials will collect cardiovascular endpoint data
Retatrutide dosage information comes from clinical trials, not approved prescribing instructions
Studies have shown that newer treatments such as computer assisted vacuum thrombectomy and mechanical thrombectomy can remove blood clots quickly while also reducing hospital length of stay, lowering the risk of bleeding or invasive surgery, and improving patient outcomes
US$ 29.19
US$ 26.39
US$ 25.22
US$ 29.85
US$ 23.89
US$ 29.34
US$ 27.71
US$ 22.88
US$ 21.80
